Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Ladis V"'
Background and aim: Dysregulation of glucose metabolism is a common complication of transfusions in Transfusion Dependent Thalassemia (TDT) patients. For early diagnosis of glucose disturbances, screening is recommended. The age of starting and the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::78cdb89276fd4677b3368702bff01483
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119353
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119353
Background: Data on the prevalence and type of endocrine disorders in β-thalassemia intermedia (β-TI) patients are scarce. This multicenter study was designed to determine the prevalence of endocrine complications and the associated risk factors in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::84a01e57a24fec7463df58e1e55d2eae
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078628
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078628
Background: More than five decades ago, thalassemia major (TDT) was fatal in the first decade of life. Survival and quality of life have improved progressively thanks to the implementation of a significant advance in diagnostic and therapeutic method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2ebb147fe7f1ce452b0304f114f58418
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121897
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121897
In adult thalassemia major (TM) patients, a number of occult and emerging endocrine complications, such as: central hypothyroidism (CH), thyroid cancer, latent hypocortisolism, and growth hormone deficiency (GHD) have emerged and been reported. As th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::73025d79b81cb943db4c14ebd9d54a32
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123726
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123726
Objectives: Beta thalassaemia major (β-TM) and sickle-cell disease (SCD) are severe haemogobinopathies requiring life-lasting, advanced medical management. In the Mediterranean region, both conditions occur with high frequency. We assessed the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::97733db41228f033a93b448432188766
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3128055
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3128055
Purpose: To evaluate whether the introduction of magnetic resonance imaging (MRI) in the management of thalassemia major (TM) patients has affected the risk of cardiac death. Materials and Methods: In all, 804 TM patients from two large reference uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::90fa6f84cd5f93fdca3b8cd61223e055
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111538
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111538
Background: With transfusions and chelation therapy, the prognosis for transfusion-dependent beta thalassaemia has changed from being fatal in early childhood to a chronic disorder with prolonged survival. Design and methods: In this historical prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b9b99828410c0855321dfd60c1477212
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129704
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129704
Abnormal iron regulation in patients with thalassaemia intermedia may lead to iron overload even in the absence of transfusions. There are limited data on iron chelator use in patients with thalassaemia intermedia and no guidelines exist for the mana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::efc9b98d8f4296476f9ecc510363732a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111872
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111872
Objectives: Cardiac complications because of transfusional iron overload are the main cause of death in thalassaemia major. New chelators and iron monitoring methods such as cardiac magnetic resonance (CMR) became available after the year 2000. We ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::96b4412b843cd186057976815eb4fcc5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3112165
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3112165
Cardiac Magnetic Resonance (CMR) has replaced all other surrogate measurements in the determination of transfusional cardiac iron overload in patients with thalassaemia major. We aimed to determine the diagnostic value of CMR T2* with respect to card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d4f0739ea693342e634b03fad20dd94c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111900
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111900